Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms
Open accessThe DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Abstract
Abnormal Rac1 signaling is linked to a number of debilitating human diseases, including cancer, cardiovascular diseases and neurodegenerative disorders. As such, Rac1 represents an attractive therapeutic target, yet the search for effective Rac1 inhibitors is still underway. Given the adverse effects associated with Rac1 signaling perturbation, cells have evolved several mechanisms to ensure the tight regulation of Rac1 signaling. Thus, characterizing these mechanisms can provide invaluable information regarding major cellular events that lead to aberrant Rac1 signaling. Importantly, this information can be utilized to further facilitate the development of effective pharmacological modulators that can restore normal Rac1 signaling. In this review, we focus on the pathological role of Rac1 signaling, highlighting the benefits and potential drawbacks of targeting Rac1 in a clinical setting. Additionally, we provide an overview of available compounds that target key Rac1 regulatory mechanisms and discuss future therapeutic avenues arising from our understanding of these mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Valencia, A., Sapp, E., Kimm, J. S., McClory, H., Reeves, P. B., Alexander, J., Ansong, K. A., Masso, N., Frosch, M. P., Kegel, K. B., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds516 · Cited by 93 · cited 1×
“enhanced survival associated with pharmacological inhibition and genetic deletion of NADPH oxidase in Huntington’s disease mouse models.(129) In addition to its role in ROS production, Rac1 and its downstream effec-”
BackgroundRetractedCalcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Nobes, C. D., & Hall, A. (1995) · Cell · doi:10.1016/0092-8674(95)90370-4 · Cited by 4,412
Etienne-Manneville, S., & Hall, A. (2002) · Nature · doi:10.1038/nature01148 · Cited by 4,201 · cited 1×
“signaling, via coupling active Rac1 to specific downstream effectors, thereby selectively activating certain Rac1-driven functions.(3,31,33,37-46) Given the diverse modes involved in Rac1 regulation, studies focused on”
BackgroundZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058 · cited 1×
“database were screened to identify compounds that can interfere with Rac1-GEF binding.(159,160) This led to the identification of a novel Rac1 inhibitor, ZINC69391,”
BackgroundInflammation in Atherosclerosis
Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736 · cited 1×
“For example, the movement of leukocytes from blood vessels into arterial walls marks a key step in the inflammatory response associated with atherosclerosis.(111) Thus, through driving leukocyte trans-endothelial migration and accumulation in arterial walls, Rac1 contributes to inflammation in response to vascular inj…”
BackgroundEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605 · cited 1×
“blast-like synoviocytes, also display tumor-like properties.(139) Given the prominent role of Rac1 in cancer, it is not surprising that Rac1 contributes to the proliferative and invasive properties of fibroblast-like synovio-”
BackgroundThe GTPase superfamily: conserved structure and molecular mechanism
Bourne, H. R., Sanders, D. A., & McCormick, F. (1991) · Nature · doi:10.1038/349117a0 · Cited by 3,392 · cited 1×
“induces a conformational change that promotes binding to downstream effectors.(147) As mentioned above, regulation of this GDP-GTP activation cycle is mediated mainly by 3 groups of proteins: GEFs, GAPs and RhoG-”
BackgroundA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610 · cited 1×
“further supporting a role for this this mutation in melanoma progression.(81) Whole exome sequencing data from 74 tumor and normal sample pairs also identified”
BackgroundZINC: A Free Tool to Discover Chemistry for Biology
Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S., & Coleman, R. G. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci3001277 · Cited by 2,509 · cited 1×
“database were screened to identify compounds that can interfere with Rac1-GEF binding.(159,160) This led to the identification of a novel Rac1 inhibitor, ZINC69391,”
BackgroundThe Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504 · cited 1×
“Rac1 P29S as an activating mutation in head and neck squamous cell carcinoma.(82) Moreover, following the”
BackgroundBloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors
Rossman, K. L., Der, C. J., & Sondek, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1587 · Cited by 1,697 · cited 1×
“Through interacting with Rac1, GEFs facilitate the exchange of GDP for GTP by promoting GDP dissociation.(148) In principle, GTP loading primes Rac1 for binding to all downstream effectors.”
BackgroundRoss, R., & Glomset, J. A. (1973) · Science · doi:10.1126/science.180.4093.1332 · Cited by 1,501
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Sahai, E., & Marshall, C. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc725 · Cited by 1,261 · cited 1×
“cell-extracellular matrix (ECM) focal adhesions as well as mediating myosin light chain (MLC) phosphorylation and cell contraction.(4,5,44,46,52,55,56) Additionally, Rac1 facilitates cancer cell invasion via controlling the expression and release of matrix metalloproteinases (MMPs), which are required for ECM proteoly…”
BackgroundExome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191 · cited 2×
“exposed melanomas in which proline 29, located in the highly conserved switch I region, is replaced by serine (P29S).(80) This mutation was also identified in a separate study aimed at mapping driver mutations in melanoma,”
BackgroundSahai, E., & Marshall, C. J. (2003) · Nature Cell Biology · doi:10.1038/ncb1019 · Cited by 1,147
Rational design and characterization of a Rac GTPase-specific small molecule inhibitor
Gao, Y., Dickerson, J. B., Guo, F., Zheng, J., & Zheng, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307512101 · Cited by 1,091 · cited 1×
“ing cascades driven by the Rac GEF Vav or the activation of the closely related small GTPases, RhoA and cell division control protein 42 homolog (Cdc42).(152) Interestingly, NSC23766-mediated Rac1 inhibition has been shown to inhibit Rac1-driven pro-tumorigenic effects in a number of cancer models.”
BackgroundRidley, A. J. (2011) · Cell · doi:10.1016/j.cell.2011.06.010 · Cited by 956 · cited 1×
“provide a link between Rac1 and WAVE2 to mediate Rac1-driven actin polymerization and lamellipodia formation.(56,150) Interestingly, Tiam1 expression also stimulates the localization of IRSp53 at Rac1-mediated”
BackgroundActivation of the NADPH oxidase involves the small GTP-binding protein p21rac1
Abo, A., Pick, E., Hall, A., Totty, N., Teahan, C. G., & Segal, A. W. (1991) · Nature · doi:10.1038/353668a0 · Cited by 954
Regulating Rho GTPases and their regulators
Hodge, R. G., & Ridley, A. J. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.67 · Cited by 872 · cited 1×
“brane targeting, via carboxyl-terminal modifications by lipid moieties.(21,24,29,30,36) Translocation of Rac1 to the plasma membrane is mediated by a series of modifications that are triggered by Rac1 prenylation.”
BackgroundTiede, I., Fritz, G., Strand, S., Poppe, D., Dvorsky, R., Strand, D., Lehr, H. A., Wirtz, S., Becker, C., Atreya, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16432 · Cited by 828
Rho GTPases and the control of cell behaviour
Hall, A. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330891 · Cited by 792
Cartilage homeostasis in health and rheumatic diseases
Goldring, M. B., & Marcu, K. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2592 · Cited by 762 · cited 1×
“This, in turn, leads to the degradation of the of articular cartilage matrix.(135) Interestingly, Rac1 was shown to mediate fibronectin fragment-induced MMP-”
BackgroundPAK Kinases Are Directly Coupled to the PIX Family of Nucleotide Exchange Factors
Manser, E., Loo, T.-H., Koh, C.-G., Zhao, Z.-S., Chen, X.-Q., Tan, L., Tan, I., Leung, T., & Lim, L. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80019-2 · Cited by 753 · cited 2×
“tor (PIX) family of GEFs, which through their Srchomology 3 (SH3) domain, bind to PAKs.(38) More”
BackgroundActivation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683 · cited 1×
“It has long been established that Rac1 drives tumor initiation, via serving as a Ras downstream effector, with in vitro data demonstrating the requirement of Rac1 for full oncogenic Ras transformation of NIH3T3 cells.(47) In vivo studies have also highlighted the importance of Rac1 in”
BackgroundDifferential Localization of Rho Gtpases in Live Cells
Michaelson, D., Silletti, J., Murphy, G., D'Eustachio, P., Rush, M., & Philips, M. R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.1.111 · Cited by 679 · cited 2×
“brane targeting, via carboxyl-terminal modifications by lipid moieties.(21,24,29,30,36) Translocation of Rac1 to the plasma membrane is mediated by a series of modifications that are triggered by Rac1 prenylation.”
BackgroundGDIs: central regulatory molecules in Rho GTPase activation
DerMardirossian, C., & Bokoch, G. M. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.05.001 · Cited by 678 · cited 1×
“3).(180,181) Additionally, determination of the crystal structure of Rac1 in complex with RhoGDI also provided”
BackgroundLocalized Rac Activation Dynamics Visualized in Living Cells
Kraynov, V. S., Chamberlain, C., Bokoch, G. M., Schwartz, M. A., Slabaugh, S., & Hahn, K. M. (2000) · Science · doi:10.1126/science.290.5490.333 · Cited by 678
Prespecification and plasticity: shifting mechanisms of cell migration
Friedl, P. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.11.001 · Cited by 667
Sander, E. E., van Delft, S., ten Klooster, J. P., Reid, T., van der Kammen, R. A., Michiels, F., & Collard, J. G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.5.1385 · Cited by 659
Rac and Rho GTPases in cancer cell motility control
Parri, M., & Chiarugi, P. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-23 · Cited by 639 · cited 2×
“cell-extracellular matrix (ECM) focal adhesions as well as mediating myosin light chain (MLC) phosphorylation and cell contraction.(4,5,44,46,52,55,56) Additionally, Rac1 facilitates cancer cell invasion via controlling the expression and release of matrix metalloproteinases (MMPs), which are required for ECM proteoly…”
BackgroundGTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo
Bustelo, X. R., Sauzeau, V., & Berenjeno, I. M. (2007) · BioEssays · doi:10.1002/bies.20558 · Cited by 634
Targeting protein prenylation for cancer therapy
Berndt, N., Hamilton, A. D., & Sebti, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3151 · Cited by 614 · cited 1×
“Interestingly, one GGTI, GGTI2418, has entered clinical trials.(176) It would be interesting to examine, whether in a clinical setting this inhib-”
BackgroundThe Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology
MacLeod, D., Dowman, J., Hammond, R., Leete, T., Inoue, K., & Abeliovich, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.008 · Cited by 564
IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling
Miki, H., Yamaguchi, H., Suetsugu, S., & Takenawa, T. (2000) · Nature · doi:10.1038/35047107 · Cited by 557 · cited 2×
“provide a link between Rac1 and WAVE2 to mediate Rac1-driven actin polymerization and lamellipodia formation.(56,150) Interestingly, Tiam1 expression also stimulates the localization of IRSp53 at Rac1-mediated”
BackgroundRegulation of NADPH Oxidases: The Role of Rac Proteins
Hordijk, P. L. (2006) · Circulation Research · doi:10.1161/01.res.0000204727.46710.5e · Cited by 525 · cited 1×
“Interestingly, Rac1 plays a crucial role in the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases.(94) For SMALL GTPASES 141”
Backgroundp47phox is required for atherosclerotic lesion progression in ApoE–/– mice
Barry-Lane, P. A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T. H., & Runge, M. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111927 · Cited by 489
Rho Guanine Dissociation Inhibitors
Olofsson, B. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(98)00063-1 · Cited by 484 · cited 1×
“3).(180,181) Additionally, determination of the crystal structure of Rac1 in complex with RhoGDI also provided”
BackgroundMechanisms of Motility in Metastasizing Cells
Yilmaz, M., & Christofori, G. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0139 · Cited by 477
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 459 · cited 1×
“generative and kidney disorders as well as arthritis.(8,12,137,140) More recently, in vivo experiments also”
BackgroundNADPH Oxidases, Reactive Oxygen Species, and the Kidney: Friend and Foe
Sedeek, M., Nasrallah, R., Touyz, R. M., & Hébert, R. L. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111112 · Cited by 456 · cited 1×
“contributes to the inflammation associated with kidney disorders.(15) For example, depletion of Rac1 in macro-”
BackgroundInhibition of Invasion of Epithelial Cells by Tiam1-Rac Signaling
Hordijk, P. L., ten Klooster, J. P., van der Kammen, R. A., Michiels, F., Oomen, L. C. J. M., & Collard, J. G. (1997) · Science · doi:10.1126/science.278.5342.1464 · Cited by 441 · cited 1×
“expression of constitutively active Rac1 was shown to antagonize Ras transformation of Madin-Darby canine kidney II (MDCKII) cells, by restoring epithelial morphology.(85) Metastasis suppressor-1 (Mtss1) was also reported to regu-”
BackgroundGeiger, T. R., & Peeper, D. S. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.07.006 · Cited by 431
De Wever, O., Nguyen, Q., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., & Mareel, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1110fje · Cited by 402
Subversion of the actin cytoskeleton during viral infection
Taylor, M. P., Koyuncu, O. O., & Enquist, L. W. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2574 · Cited by 395 · cited 1×
“Additionally, Rac1 regulates the vesicular trafficking of viral particles of adenoviruses, African swine fever virus as well as Ebola virus.(144) However,”
BackgroundRho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration
Stankiewicz, T. R., & Linseman, D. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00314 · Cited by 391 · cited 2×
“generative and kidney disorders as well as arthritis.(8,12,137,140) More recently, in vivo experiments also”
BackgroundRole of Rac1 and Oxygen Radicals in Collagenase-1 Expression Induced by Cell Shape Change
Kheradmand, F., Werner, E., Tremble, P., Symons, M., & Werb, Z. (1998) · Science · doi:10.1126/science.280.5365.898 · Cited by 391
Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours
Malliri, A., van der Kammen, R. A., Clark, K., van der Valk, M., Michiels, F., & Collard, J. G. (2002) · Nature · doi:10.1038/nature00848 · Cited by 384 · cited 1×
“gressed to malignancy, thus indicating that Tiam1-Rac1 signaling inhibits cancer progression.(88) Similarly, Tiam1”
BackgroundSelf-citationInhibition of Ras for Cancer Treatment: The Search Continues
Baines, A. T., Xu, D., & Der, C. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.121 · Cited by 382 · cited 1×
“cation switch, a phenomenon observed with K-Ras and neuroblastoma Ras viral (v-ras) oncogene homolog (N-Ras) following treatment with FTase inhibitors.(177) Inhibitors of palmitoylation constitute the third class of compounds targeting Rac1 spatial regulation”
BackgroundInteraction of Rac with p67 phox and Regulation pf Phagocytic NADPH Oxidase Activity
Diekmann, D., Abo, A., Johnston, C., Segal, A. W., & Hall, A. (1994) · Science · doi:10.1126/science.8036496 · Cited by 382
Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification
Roberts, P. J., Mitin, N., Keller, P. J., Chenette, E. J., Madigan, J. P., Currin, R. O., Cox, A. D., Wilson, O., Kirschmeier, P., & Der, C. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800882200 · Cited by 362 · cited 2×
“brane targeting, via carboxyl-terminal modifications by lipid moieties.(21,24,29,30,36) Translocation of Rac1 to the plasma membrane is mediated by a series of modifications that are triggered by Rac1 prenylation.”
BackgroundThe host type I interferon response to viral and bacterial infections
PERRY, A. K., CHEN, G., ZHENG, D., TANG, H., & CHENG, G. (2005) · Cell Research · doi:10.1038/sj.cr.7290309 · Cited by 360 · cited 1×
“demonstrating the complexity of Rac1 signaling in infectious diseases, Rac1 is also implicated in the innate immune response.(145,146) Therefore, targeting Rac1 to combat infection requires a detailed under-”
BackgroundSOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model
Harraz, M. M., Marden, J. J., Zhou, W., Zhang, Y., Williams, A., Sharov, V. S., Nelson, K., Luo, M., Paulson, H., Schöneich, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34060 · Cited by 356
Crystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1
Worthylake, D. K., Rossman, K. L., & Sondek, J. (2000) · Nature · doi:10.1038/35047014 · Cited by 355 · cited 1×
“of Tiam1, which provided important details of the mechanism and specific sites involved in Rac1-GEF interactions.(151) This information paved the way for structurebased virtual screening that led to the discovery of NSC23766, the first selective Rac1 inhibitor.”
BackgroundRac1 GTPase: A “Rac” of All Trades
Bosco, E. E., Mulloy, J. C., & Zheng, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8552-x · Cited by 350
Schnelzer, A., Prechtel, D., Knaus, U., Dehne, K., Gerhard, M., Graeff, H., Harbeck, N., Schmitt, M., & Lengyel, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203621 · Cited by 347 · cited 1×
“ignated Rac1b, has also been reported in a number of tumor types, including colorectal cancer, breast cancer and lung cancer.(71,72,73) Unlike Rac1, Rac1b harbors an additional 57”
BackgroundShutes, A., Onesto, C., Picard, V., Leblond, B., Schweighoffer, F., & Der, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703571200 · Cited by 336 · cited 17×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
BackgroundInfluentialJudkins, C. P., Diep, H., Broughton, B. R. S., Mast, A. E., Hooker, E. U., Miller, A. A., Selemidis, S., Dusting, G. J., Sobey, C. G., & Drummond, G. R. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00799.2009 · Cited by 299
Regulation of innate immunity by Rho GTPases
Bokoch, G. M. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.01.002 · Cited by 298 · cited 1×
“demonstrating the complexity of Rac1 signaling in infectious diseases, Rac1 is also implicated in the innate immune response.(145,146) Therefore, targeting Rac1 to combat infection requires a detailed under-”
BackgroundStatins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Zhou, Q., & Liao, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787315684 · Cited by 294 · cited 18×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
BackgroundInfluentialThe 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1
Chou, M. M., & Blenis, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81257-x · Cited by 292 · cited 1×
“Rac1 association with p70 S6, which was previously reported to enhance p70 S6 activation.(149) Additionally, GEFs can also dictate Rac1 signaling, through directly”
BackgroundLeukocyte transendothelial migration: orchestrating the underlying molecular machinery
Worthylake, R. A., & Burridge, K. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00253-2 · Cited by 281 · cited 1×
“Thus, through driving leukocyte trans-endothelial migration and accumulation in arterial walls, Rac1 contributes to inflammation in response to vascular injury.(112) Together with regulating NADPH assembly and activa-”
BackgroundRequirement of Rac1 in the development of cardiac hypertrophy
Satoh, M., Ogita, H., Takeshita, K., Mukai, Y., Kwiatkowski, D. J., & Liao, J. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510444103 · Cited by 272 · cited 1×
“stress, which correlated with decreased cardiac hypertrophy despite being subjected to angiotensin II-induced hypertensive stress.(100) All together, this demonstrates that Rac1-mediated modulation of NADPH assembly”
BackgroundRAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
Bid, H. K., Roberts, R. D., Manchanda, P. K., & Houghton, P. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0164 · Cited by 265 · cited 1×
“Interestingly, NSC23766-mediated Rac1 inhibition has been shown to inhibit Rac1-driven pro-tumorigenic effects in a number of cancer models.(153) The protective effects of NSC23766 also extend to other disease models, including neurode-”
BackgroundOverexpression of RhoA, Rac1, and Cdc42 GTPases Is Associated with Progression in Testicular Cancer
Kamai, T., Yamanishi, T., Shirataki, H., Takagi, K., Asami, H., Ito, Y., & Yoshida, K.-I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0436-03 · Cited by 255
Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors
Jordan, P., Brazão, R., Boavida, M. G., Gespach, C., & Chastre, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203233 · Cited by 253
Wu, D.-C., Ré, D. B., Nagai, M., Ischiropoulos, H., & Przedborski, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603670103 · Cited by 252 · cited 1×
“This, in turn, promotes Rac1-driven activation of NADPH oxidase and ROS overproduction,(126,127) which are known to contribute to the motor neuron degeneration attributed to SOD1 mutations.(128) Similarly, abnor-”
BackgroundRho GTPase expression in tumourigenesis: Evidence for a significant link
del Pulgar, T. G., Benitah, S. A., Valerón, P. F., Espina, C., & Lacal, J. C. (2005) · BioEssays · doi:10.1002/bies.20238 · Cited by 240 · cited 1×
“strated by the reported deregulation of Rac1 protein level and activity in a variety of tumors, which, in turn, facilitates tumor initiation, progression and metastasis.(6,52,68) For example, Rac1 overexpression has been implicated in the”
BackgroundShibata, S., Mu, S., Kawarazaki, H., Muraoka, K., Ishizawa, K.-I., Yoshida, S., Kawarazaki, W., Takeuchi, M., Ayuzawa, N., Miyoshi, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43124 · Cited by 236
An essential role for Rac1 in endothelial cell function and vascular development
Tan, W., Palmby, T. R., Gavard, J., Amornphimoltham, P., Zheng, Y., & Gui, J. S. (2008) · The FASEB Journal · doi:10.1096/fj.07-096438 · Cited by 227
Akt Protein Kinase Inhibits Rac1-GTP Binding through Phosphorylation at Serine 71 of Rac1
Kwon, T., Kwon, D. Y., Chun, J., Kim, J. H., & Kang, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.423 · Cited by 226
Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPase
Montalvo-Ortiz, B. L., Castillo-Pichardo, L., Hernández, E., Humphries-Bickley, T., De La Mota-Peynado, A., Cubano, L. A., Vlaar, C. P., & Dharmawardhane, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334524 · Cited by 213 · cited 1×
“Instead EHop-016 blocks Rac1-Vav2 binding and has been shown to suppress Rac1-driven directed cell migration of metastatic cancer cells.(158) This highlights the potential importance of EHop016 and similar compounds in combating Rac1-mediated”
BackgroundThomas, M., Gavrila, D., McCormick, M. L., Miller, F. J., Daugherty, A., Cassis, L. A., Dellsperger, K. C., & Weintraub, N. L. (2006) · Circulation · doi:10.1161/circulationaha.105.607168 · Cited by 206
Buchsbaum, R. J., Connolly, B. A., & Feig, L. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4073-4085.2002 · Cited by 198 · cited 1×
“kinase 14 (p38), both GEFs couple activated Rac1 to the p38 signaling cascade over the Jun N-terminal kinase (JNK) signaling cascade.(39) In addition to IB2/JIP2, Tiam1 binding to spinophilin, another scaffolding protein, is also implicated in modulating Rac1 downstream”
BackgroundDeregulation of Rho GTPases in cancer
Porter, A. P., Papaioannou, A., & Malliri, A. (2016) · Small GTPases · doi:10.1080/21541248.2016.1173767 · Cited by 194 · cited 2×
“regulators was considered the major mode of Rac1 signaling perturbation in cancer.(6) However, advancements in screening methodologies have also enabled the 140 H.”
BackgroundSelf-citationA palmitoylation switch mechanism regulates Rac1 function and membrane organization
Navarro‐Lérida, I., Sánchez‐Perales, S., Calvo, M., Rentero, C., Zheng, Y., Enrich, C., & Del Pozo, M. A. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.446 · Cited by 190 · cited 3×
“This effect was also associated with decreased Rac1 GTP loading.(29) This suggests”
BackgroundDirect Evidence for Cytokine Involvement in Neointimal Hyperplasia
Rectenwald, J. E., Moldawer, L. L., Huber, T. S., Seeger, J. M., & Ozaki, C. K. (2000) · Circulation · doi:10.1161/01.cir.102.14.1697 · Cited by 188 · cited 1×
“in response to tumor necrosis factor-a (TNF-a) stimulation.(106) Additionally, Rac1 regulates endothelial perme-”
BackgroundRac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division
Michaelson, D., Abidi, W., Guardavaccaro, D., Zhou, M., Ahearn, I., Pagano, M., & Philips, M. R. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801047 · Cited by 184
Sussman, M. A., Welch, S., Walker, A., Klevitsky, R., Hewett, T. E., Price, R. L., Schaefer, E., & Yager, K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8497 · Cited by 183 · cited 17×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
BackgroundInfluentialNADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies
Sirker, A., Zhang, M., & Shah, A. M. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0190-z · Cited by 179 · cited 1×
“Deregulation of NADPH oxidases and ROS overproduction have been extensively linked to cardiovascular diseases.(97) Thus, it is likely that aberrant Rac1 activation is responsible, at least partially, for the”
BackgroundExpression of seven main Rho family members in gastric carcinoma
Pan, Y., Bi, F., Liu, N., Xue, Y., Yao, X., Zheng, Y., & Fan, D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.108 · Cited by 178
Singh, A., Karnoub, A. E., Palmby, T. R., Lengyel, E., Sondek, J., & Der, C. J. (2004) · Oncogene · doi:10.1038/sj.onc.1208182 · Cited by 174 · cited 1×
“Importantly, expression of Rac1bwas shown to promote growth transformation in NIH3T3 cells.(76) Additionally, depletion of Rac1b in colorectal cancer cells results in a significant reduction in”
BackgroundVendrov, A. E., Hakim, Z. S., Madamanchi, N. R., Rojas, M., Madamanchi, C., & Runge, M. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152629 · Cited by 173 · cited 1×
“Inhibition of NADPH and the associated ROS production attenuates aortic atherosclerosis in vivo.(103) It, thus, follows that Rac1 inhibition or depletion would also mimic this phenotype.”
BackgroundThe E3 Ubiquitin-Ligase HACE1 Catalyzes the Ubiquitylation of Active Rac1
Torrino, S., Visvikis, O., Doye, A., Boyer, L., Stefani, C., Munro, P., Bertoglio, J., Gacon, G., Mettouchi, A., & Lemichez, E. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.08.015 · Cited by 170
SUMOylation of the GTPase Rac1 is required for optimal cell migration
Castillo-Lluva, S., Tatham, M. H., Jones, R. C., Jaffray, E. G., Edmondson, R. D., Hay, R. T., & Malliri, A. (2010) · Nature Cell Biology · doi:10.1038/ncb2112 · Cited by 170 · cited 1×
“press the associated Rac1-downstream signaling cascades.(26) This might be particularly relevant in selectively targeting Rac1 pro-migratory properties in a clinical set-”
BackgroundSelf-citationThe RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF
Watson, I. R., Li, L., Cabeceiras, P. K., Mahdavi, M., Gutschner, T., Genovese, G., Wang, G., Fang, Z., Tepper, J. M., Stemke-Hale, K., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1232-t · Cited by 169
Requirement for Rac1 in a K-ras–Induced Lung Cancer in the Mouse
Kissil, J. L., Walmsley, M. J., Hanlon, L., Haigis, K. M., Bender Kim, C. F., Sweet-Cordero, A., Eckman, M. S., Tuveson, D. A., Capobianco, A. J., Tybulewicz, V. L. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2300 · Cited by 167
The diverse roles of Rac signaling in tumorigenesis
Mack, N. A., Whalley, H. J., Castillo-Lluva, S., & Malliri, A. (2011) · Cell Cycle · doi:10.4161/cc.10.10.15612 · Cited by 167 · cited 1×
“cell-extracellular matrix (ECM) focal adhesions as well as mediating myosin light chain (MLC) phosphorylation and cell contraction.(4,5,44,46,52,55,56) Additionally, Rac1 facilitates cancer cell invasion via controlling the expression and release of matrix metalloproteinases (MMPs), which are required for ECM proteoly…”
BackgroundSelf-citationBenitah, S. A., Valerón, P. F., Aelst, L. V., Marshall, C. J., & Lacal, J. C. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.10.002 · Cited by 165
p21-activated Kinase Regulates Endothelial Permeability through Modulation of Contractility
Stockton, R. A., Schaefer, E., & Schwartz, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408877200 · Cited by 164 · cited 3×
“quent activation of its downstream effector PAK in endothelial cells enhances junction permeability through regulating adherens junctions as well as promoting cell contractility through MLC phosphorylation.(109) Indeed, displacement of active PAK from endothelial cell-cell”
BackgroundNakaya, Y., Kuroda, S., Katagiri, Y. T., Kaibuchi, K., & Takahashi, Y. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.08.003 · Cited by 160
Pracyk, J. B., Tanaka, K., Hegland, D. D., Kim, K. S., Sethi, R., Rovira, I. I., Blazina, D. R., Lee, L., Bruder, J. T., Kovesdi, I., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2552 · Cited by 149 · cited 1×
“example as a consequence of mechanical stress and ischemic injury.(90) In vivo studies also highlight the role of aberrant Rac1 activation in cardiovascular diseases.”
BackgroundAlternative Splicing of Rac1 Generates Rac1b, a Self-activating GTPase
Fiegen, D., Haeusler, L.-C., Blumenstein, L., Herbrand, U., Dvorsky, R., Vetter, I. R., & Ahmadian, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310281200 · Cited by 148
IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation
Oberoi‐Khanuja, T. K., Dogan, T., Hocking, J. C., Scholz, R., Mooz, J., Anderson, C. L., Karreman, C., zu Heringdorf, D. M., Schmidt, G., Ruonala, M. O., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.423 · Cited by 147
Crystal Structure of the Rac1−RhoGDI Complex Involved in NADPH Oxidase Activation,
Grizot, S., Fauré, J., Fieschi, F., Vignais, P. V., Dagher, M.-C., & Pebay-Peyroula, E. (2001) · Biochemistry · doi:10.1021/bi010288k · Cited by 146 · cited 1×
“important details regarding their interaction sites and how RhoGDIs mask Rac1 lipid modifications.(182) Utiliz-”
BackgroundReactive Oxygen Species in Mechanical Stress-Induced Cardiac Hypertrophy
Aikawa, R., Nagai, T., Tanaka, M. H., Zou, Y., Ishihara, T., Takano, H., Hasegawa, H., Akazawa, H., Mizukami, M., Nagai, R., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6068 · Cited by 145 · cited 1×
“has been shown to impede ROS production in cardiomyocytes following mechanical stress-induced cardiac hypertrophy.(98) Similarly, Rac1 inactivation abolishes angiotensin II-induced ROS generation in cardiomyocytes.”
BackgroundMatrix-specific p21-activated kinase activation regulates vascular permeability in atherogenesis
Orr, A. W., Stockton, R., Simmers, M. B., Sanders, J. M., Sarembock, I. J., Blackman, B. R., & Schwartz, M. A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200609008 · Cited by 141 · cited 2×
“Consistently, inhibition of PAK in vivo reduces endothelial permeability in atherosclerosisprone regions.(110) This indicates that increased activation of Rac1-PAK signaling can stimulate atherosclerosis,”
BackgroundNishida, M., Tanabe, S., Maruyama, Y., Mangmool, S., Urayama, K., Nagamatsu, Y., Takagahara, S., Turner, J. H., Kozasa, T., Kobayashi, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409710200 · Cited by 138 · cited 1×
“Similarly, Rac1 inactivation abolishes angiotensin II-induced ROS generation in cardiomyocytes.(99) Importantly, cardiomyocyte-specific Rac1 deletion in a transgenic mouse model was associated with reduced NADPH activation and myocardial oxidative”
BackgroundDésiré, L., Bourdin, J., Loiseau, N., Peillon, H., Picard, V., De Oliveira, C., Bachelot, F., Leblond, B., Taverne, T., Beausoleil, E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507913200 · Cited by 135
Transforming mutations of RAC guanosine triphosphatases in human cancers
Kawazu, M., Ueno, T., Kontani, K., Ogita, Y., Ando, M., Fukumura, K., Yamato, A., Soda, M., Takeuchi, K., Miki, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216141110 · Cited by 130 · cited 2×
“All 3 mutations were also found to be highly transforming in a number of cancer cell lines.(83) Given their prevalence in a large number of cancers,(83) together with evidence implicating mutations, such as Rac1 P29S”
BackgroundThe Rac Activator Tiam1 Is a Wnt-responsive Gene That Modifies Intestinal Tumor Development
Malliri, A., Rygiel, T. P., van der Kammen, R. A., Song, J., Engers, R., Hurlstone, A. F. L., Clevers, H. C., & Collard, J. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507582200 · Cited by 130 · cited 2×
“For example, while far fewer skin tumors developed in carcinogen-treated Tiam1 knockout mice, proportionally they more often progressed to malignancy, thus indicating that Tiam1-Rac1 signaling inhibits cancer progression.88 Similarly, Tiam1 deficiency in adenomatous polyposis coli (APC) mutant multiple intestinal neop…”
BackgroundSelf-citationMatos, P., Collard, J. G., & Jordan, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308215200 · Cited by 129
Apolloni, S., Parisi, C., Pesaresi, M. G., Rossi, S., Carrì, M. T., Cozzolino, M., Volonté, C., & D’Ambrosi, N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203262 · Cited by 128
AL-Hadithy, A. H., de Boer, N. K. H., Derijks, L. J. J., Escher, J. C., Mulder, C. J. J., & Brouwers, J. R. B. J. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.09.029 · Cited by 125 · cited 1×
“In fact, thiopurines, a class of drugs currently utilized for the management of chronic inflammatory bowel diseases, have been shown to suppress Rac1 activity.(142,143) Thus, inhibiting Rac1 activation and the associated inflammatory and immune”
BackgroundThe Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis
Zhou, C., Licciulli, S., Avila, J. L., Cho, M., Troutman, S. A., Jiang, P., Kossenkov, A. V., Showe, L. C., Liu, Q., Vachani, A., et al. (2012) · Oncogene · doi:10.1038/onc.2012.99 · Cited by 121 · cited 2×
“ignated Rac1b, has also been reported in a number of tumor types, including colorectal cancer, breast cancer and lung cancer.(71,72,73) Unlike Rac1, Rac1b harbors an additional 57”
BackgroundRac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)
Chan, D., Citro, A., Cordy, J. M., Shen, G. C., & Wolozin, B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234005 · Cited by 120 · cited 1×
“Interestingly, expression of Rac1 rescues neurite retraction and neuronal cell death induced by LRRK2 mutants.(125) This”
BackgroundLe Menuet, D., Isnard, R., Bichara, M., Viengchareun, S., Muffat-Joly, M., Walker, F., Zennaro, M.-C., & Lombès, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103984200 · Cited by 117 · cited 1×
“and nuclear translocation of the mineralocorticoid receptor, 12-14 a member of the steroid receptor family that plays an essential role in the progression of kidney diseases.(11) Importantly, inhibition of Rac1 was shown to have renoprotective functions by counteracting the hyperactivation of the mineralocorticoid rec…”
BackgroundBuchsbaum, R. J., Connolly, B. A., & Feig, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207876200 · Cited by 116 · cited 1×
“mediated p70 S6 kinase activation, while suppressing Tiam1-Rac1-mediated PAK activation.(40) The observed”
BackgroundBacteria-host relationship: ubiquitin ligases as weapons of invasion
Maculins, T., Fiskin, E., Bhogaraju, S., & Dikic, I. (2016) · Cell Research · doi:10.1038/cr.2016.30 · Cited by 115
Wang, Z., Pedersen, E., Basse, A. L., Lefever, T., Peyrollier, K., Kapoor, S., Mei, Q., Karlsson, R. T. G., Chrostek‐Grashoff, A., & Brakebusch, C. (2010) · Oncogene · doi:10.1038/onc.2010.95 · Cited by 113 · cited 1×
“both Kirsten rat sarcoma viral oncogene (K-Ras)induced lung cancer(48) and Harvey rat sarcoma viral oncogene (H-Ras)-induced skin cancer.(49) Similarly to other Rho GTPases, Rac1 is also implicated in cell cycle”
BackgroundA Cell Active Chemical GEF Inhibitor Selectively Targets the Trio/RhoG/Rac1 Signaling Pathway
Bouquier, N., Vignal, E., Charrasse, S., Weill, M., Schmidt, S., Léonetti, J., Blangy, A., & Fort, P. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.04.012 · Cited by 111
Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression
Stallings-Mann, M. L., Waldmann, J., Zhang, Y., Miller, E., Gauthier, M. L., Visscher, D. W., Downey, G. P., Radisky, E. S., Fields, A. P., & Radisky, D. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004062 · Cited by 110 · cited 2×
“initiation and progression, with expression of Rac1b in lung epithelial cells enhancing spontaneous tumor formation and promoting EMT.(78) Additionally, similarly to Rac1, Rac1b is also required for K-Ras-induced lung cancer in transgenic mouse models.”
BackgroundEngers, R., Springer, E., Michiels, F., Collard, J. G., & Gabbert, H. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105049200 · Cited by 108 · cited 1×
“was also shown to impede cellular invasion through the upregulation of tissue inhibitor of metalloproteinase-1 (TIMP-1) and -2 (TIMP-2), thereby counteracting MMPinduced ECM degradation.(87) The protective role of Rac1 in cancer has also been demonstrated in vivo.”
BackgroundKawarazaki, W., Nagase, M., Yoshida, S., Takeuchi, M., Ishizawa, K., Ayuzawa, N., Ueda, K., & Fujita, T. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011070734 · Cited by 102
Tourette, C., Li, B., Bell, R., O'Hare, S., Kaltenbach, L. S., Mooney, S. D., & Hughes, R. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523696 · Cited by 101 · cited 1×
“tor PAK have been shown to interact with mutant huntingtin in a yeast 2-hybrid screen.(130) Mutant huntingtin”
BackgroundVirtual Screening Approach for the Identification of New Rac1 Inhibitors
Ferri, N., Corsini, A., Bottino, P., Clerici, F., & Contini, A. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8015987 · Cited by 100 · cited 4×
“Indeed, a pharmacophore virtual screening approach led to the identification of 5 compounds that selectively inhibit Rac1 GTP loading while not affecting RhoA and Cdc42 activation, 2 of which, ZINC08010136 and ZINC07949036, function through inhibiting Rac1-Tiam1 binding with potencies greater than NSC23766.”
BackgroundInfluentialKanekura, K., Hashimoto, Y., Kita, Y., Sasabe, J., Aiso, S., Nishimoto, I., & Matsuoka, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410508200 · Cited by 99
Tiam1-IRSp53 Complex Formation Directs Specificity of Rac-Mediated Actin Cytoskeleton Regulation
Connolly, B. A., Rice, J., Feig, L. A., & Buchsbaum, R. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4602-4614.2005 · Cited by 98 · cited 3×
“For example, Tiam1 was shown to bind directly to the Rac1 effector insulin receptor tyrosine kinase substrate p53 (IRSp53), thus enhancing its interaction with activated Rac1 and the WASP-family verprolin-homologous protein 2 (WAVE2).41 IRSp53 has previously been reported to provide a link between Rac1 and WAVE2 to me…”
BackgroundInfluentialRac1 Nucleocytoplasmic Shuttling Drives Nuclear Shape Changes and Tumor Invasion
Navarro‐Lérida, I., Pellinen, T. S., Sánchez, S. A., Guadamillas, M. C., Wang, Y., Mirtti, T. K., Calvo, E., & del Pozo, M. Á. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.12.019 · Cited by 98 · cited 2×
“the nucleocytoplasmic shuttling of Rac1 has been implicated in regulating cell cycle progression,(170) nuclear membrane shape and actin polymerization in the nucleus.(171) Therefore, by stimulating nuclear Rac1 degradation, the protective effects of statins might also”
BackgroundCriss, A. K., Ahlgren, D. M., Jou, T., McCormick, B. A., & Casanova, J. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.7.1331 · Cited by 97
Hadano, S., Kunita, R., Otomo, A., Suzuki-Utsunomiya, K., & Ikeda, J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.010 · Cited by 95 · cited 1×
“infantile-onset ascending hereditary spastic paralysis.(121)”
Tanaka, S.-I., Fukumoto, Y., Nochioka, K., Minami, T., Kudo, S., Shiba, N., Takai, Y., Williams, C. L., Liao, J. K., & Shimokawa, H. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300922 · Cited by 91 · cited 17×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
BackgroundInfluentialThe tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation
Castillo‐Lluva, S., Tan, C.-T., Daugaard, M., Sorensen, P. H. B., & Malliri, A. (2012) · Oncogene · doi:10.1038/onc.2012.189 · Cited by 90
Self-citationMarei, H., Carpy, A., Woroniuk, A., Vennin, C., White, G., Timpson, P., Macek, B., & Malliri, A. (2016) · Nature Communications · doi:10.1038/ncomms10664 · Cited by 88 · cited 2×
“FLII interaction, indicating a GEF-specific modulation of Rac1-effector binding.(44) Indeed, comparative quantitative proteomic analysis of the Rac1 interactome revealed that Tiam1 and P-Rex1 stimulate Rac1 association with GEF-specific effector pools that could account”
BackgroundSelf-citationALS2/Alsin Regulates Rac-PAK Signaling and Neurite Outgrowth
Tudor, E. L., Perkinton, M. S., Schmidt, A., Ackerley, S., Brownlees, J., Nicholas Jacobsen, J. O., Byers, H. L., Ward, M., Hall, A., Leigh, P. N., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506216200 · Cited by 85 · cited 1×
“Under physiological conditions, alsin serves as a Rac1 GEF that mediates Rac1-driven neurite outgrowth.(122)”
BackgroundIn vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I
Lu, J., Chan, L. N., Fiji, H. D. G., Dahl, R. S., Kwon, O., & Tamanoi, F. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1122 · Cited by 85 · cited 1×
“was associated with reduced tumor growth concomitant with inhibition of protein geranylgeranylation.(173) Similar effects were also observed in a non-small cell lung cancer xenograft model.”
ResultYamanaka, K., Vande Velde, C., Eymard-Pierre, E., Bertini, E., Boespflug-Tanguy, O., & Cleveland, D. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635267100 · Cited by 84 · cited 1×
“Intriguingly, alsin mutants associated with motor neuron diseases are rapidly degraded when expressed in human cells.(123) This suggests that the loss-of-function of alsin, and by association failure to activate Rac1, might play a”
BackgroundCardama, G., Comin, M., Hornos, L., Gonzalez, N., Defelipe, L., Turjanski, A., Alonso, D., Gomez, D., & Menna, P. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113136660334 · Cited by 83 · cited 2×
“Indeed, further in vitro validation of this compound demonstrated the ability of ZINC69391 to interfere with Rac1-Tiam1 binding.(161) However, it is unclear whether this effect is limited to Tiam1 or extends”
BackgroundBiomechanical regulation of matrix metalloproteinase‐9 in cultured chondrocytes
Jin, G., Sah, R. L., Li, Y.-S. J., Lotz, M., Shyy, J. Y., & Chien, S. (2000) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100180608 · Cited by 81
Multifaceted Role of Rho Proteins in Angiogenesis
Merajver, S. D., & Usmani, S. Z. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9002-8 · Cited by 80
Lv, Z., Hu, M., Zhen, J., Lin, J., Wang, Q., & Wang, R. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.11.003 · Cited by 80
Palmitoyl acyltransferase assays and inhibitors (Review)
Draper, J. M., & Smith, C. D. (2009) · Molecular Membrane Biology · doi:10.1080/09687680802683839 · Cited by 79 · cited 3×
“As such, a number of inhibitors have been developed against PATs.178,179 Although the therapeutic potential of these compounds is yet to be elucidated in different diseases models, inhibition of palmitoylation has been shown to induce an increased perinuclear localization of Rac1 as opposed to its normal subcellular d…”
BackgroundJoyce, P. L., & Cox, A. D. (2003) · PubMed · Cited by 78
Alsin/Rac1 signaling controls survival and growth of spinal motoneurons
Jacquier, A., Buhler, E., Schäfer, M. K. E., Bohl, D., Blanchard, S., Beclin, C., & Haase, G. (2006) · Annals of Neurology · doi:10.1002/ana.20886 · Cited by 77 · cited 17×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
BackgroundInfluentialGEFs: Dual regulation of Rac1 signaling
Marei, H., & Malliri, A. (2017) · Small GTPases · doi:10.1080/21541248.2016.1202635 · Cited by 77 · cited 2×
“for the contrasting roles of these 2 GEFs in regulating Rac1-driven cell migration.(45,46) Thus, all together this”
BackgroundSelf-citationZhu, S., Lü, P., Liu, H., Chen, P., Wu, Y. R., Wang, Y., Sun, H., Zhang, X., Xia, Q., Heng, B. C., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203901 · Cited by 75 · cited 3×
“generative and kidney disorders as well as arthritis.(8,12,137,140) More recently, in vivo experiments also”
BackgroundVisvikis, O., Lorès, P., Boyer, L., Chardin, P., Lemichez, E., & Gâcon, G. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06209.x · Cited by 73
Increased Rac1b Expression Sustains Colorectal Tumor Cell Survival
Matos, P., & Jordan, P. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0008 · Cited by 73 · cited 1×
“cell viability, demonstrating the importance of Rac1b overexpression for colorectal cancer cell survival.(77) More recently, in vivo data also implicated Rac1b in lung cancer”
BackgroundMuise, A. M., Walters, T., Xu, W., Shen–Tu, G., Guo, C., Fattouh, R., Lam, G. Y., Wolters, V. M., Bennitz, J., van Limbergen, J., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.057 · Cited by 70 · cited 1×
“phisms, has been shown to play a role in the pathogenesis of chronic inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease.(9) In fact, thiopurines, a class of drugs currently utilized for the management of chronic inflammatory bowel diseases, have been shown to suppress Rac1 activity.”
BackgroundSerine-71 Phosphorylation of Rac1 Modulates Downstream Signaling
Schwarz, J., Proff, J., Hävemeier, A., Ladwein, M., Rottner, K., Barlag, B., Pich, A., Tatge, H., Just, I., & Gerhard, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044358 · Cited by 69 · cited 1×
“signaling, via coupling active Rac1 to specific downstream effectors, thereby selectively activating certain Rac1-driven functions.(3,31,33,37-46) Given the diverse modes involved in Rac1 regulation, studies focused on”
BackgroundPechlivanis, M., & Kuhlmann, J. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.09.017 · Cited by 68
Proteasome-mediated Degradation of Rac1-GTP during Epithelial Cell Scattering
Lynch, E. A., Stall, J. N., Schmidt, G., Chavrier, P., & D’Souza‐Schorey, C. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0779 · Cited by 66
Tyrosine Phosphorylation of Rac1: A Role in Regulation of Cell Spreading
Chang, F., Lemmon, C., Lietha, D., Eck, M., & Romer, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028587 · Cited by 65
Bosco, E. E., Kumar, S., Marchioni, F., Biesiada, J., Kordos, M., Szczur, K., Meller, J., Seibel, W. L., Mizrahi, A., Pick, E., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.017 · Cited by 64 · cited 17×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
MethodInfluentialLoucks, F. A., Le, S. S., Zimmermann, A. K., Ryan, K. R., Barth, H., Aktories, K., & Linseman, D. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03802.x · Cited by 58
Mitochondrial redox signalling by p66Shc mediates ALS-like disease through Rac1 inactivation
Pesaresi, M. G., Amori, I., Giorgi, C., Ferri, A., Fiorenzo, P., Gabanella, F., Salvatore, A. M., Giorgio, M., Pelicci, P. G., Pinton, P., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr347 · Cited by 58
Targeting protein palmitoylation: selective inhibitors and implications in disease
Chavda, B., Arnott, J. A., & Planey, S. L. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.933802 · Cited by 57 · cited 2×
“As such, a number of inhibitors have been developed against PATs.178,179 Although the therapeutic potential of these compounds is yet to be elucidated in different diseases models, inhibition of palmitoylation has been shown to induce an increased perinuclear localization of Rac1 as opposed to its normal subcellular d…”
BackgroundChan, A. Y., Akhtar, M., Brenner, M., Zheng, Y., Gulko, P. S., & Symons, M. H. (2007) · Molecular Medicine · doi:10.2119/2007-00025.chan · Cited by 54 · cited 2×
“generative and kidney disorders as well as arthritis.(8,12,137,140) More recently, in vivo experiments also”
BackgroundTong, J., Li, L., Ballermann, B., & Wang, Z. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00822-13 · Cited by 53 · cited 1×
“signaling, via coupling active Rac1 to specific downstream effectors, thereby selectively activating certain Rac1-driven functions.(3,31,33,37-46) Given the diverse modes involved in Rac1 regulation, studies focused on”
BackgroundRac-ing to the plasma membrane: The long and complex work commute of Rac1 during cell signaling
Bustelo, X. R., Ojeda, V., Barreira, M., Sauzeau, V., & Castro-Castro, A. (2012) · Small GTPases · doi:10.4161/sgtp.19111 · Cited by 53 · cited 2×
“brane targeting, via carboxyl-terminal modifications by lipid moieties.(21,24,29,30,36) Translocation of Rac1 to the plasma membrane is mediated by a series of modifications that are triggered by Rac1 prenylation.”
BackgroundRac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene
Wang, P., Niidome, T., Akaike, A., Kihara, T., & Sugimoto, H. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22039 · Cited by 52 · cited 1×
“shown to regulate the transcription and expression of the amyloid precursor protein (APP), the proteolytic cleavage precursor of amyloid-b.(132) Additionally, inhibition of Rac1 was shown to reduce g-secretase-dependent APP cleavage.”
BackgroundSantibanez, J. F., Krstić, J., Fabra, À., Cano, A., & Quintanilla, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.042 · Cited by 52
Long, D. L., Willey, J. S., & Loeser, R. F. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37922 · Cited by 49 · cited 1×
“Consistently, active Rac1 was detected in osteoarthritis cartilages.(136) Rac1 was also shown to promote expression of ADAMmetallopeptidase with thrombospondin type 1 motif 5 (ADAMTS-5),(137) an enzyme responsible for cleaving aggrecan, a major cartilage pro-”
BackgroundUbiquitylation of active Rac1 by the E3 Ubiquitin-Ligase HACE1
Mettouchi, A., & Lemichez, E. (2012) · Small GTPases · doi:10.4161/sgtp.19221 · Cited by 46
Ferri, N., Colombo, G., Ferrandi, C., Raines, E. W., Levkau, B., & Corsini, A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.139881 · Cited by 42 · cited 2×
“Additionally, this was associated with reduced collagen degradation.(166) As indicated earlier, Rac1 contributes to the accumulation of SMCs”
BackgroundNagase, M., Kurihara, H., Aiba, A., Young, M. J., & Sakai, T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150886 · Cited by 41 · cited 1×
“phages was shown to suppress lipopolysaccharide (LPS)-inflammation-mediated kidney injury.(16) Interest-”
BackgroundHuh, J. Y., Son, D. J., Lee, Y., Lee, J., Kim, B., Lee, H. M., Jo, H., Choi, S., Ha, H., & Chung, M.-H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.023 · Cited by 41 · cited 1×
“accumulation.(184) This further highlights the therapeutic”
Marinković, G., Hibender, S., Hoogenboezem, M., van Broekhoven, A., Girigorie, A. F., Bleeker, N., Hamers, A. A. J., Stap, J., van Buul, J. D., de Vries, C. J. M., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301394 · Cited by 41
Zimonjic, D. B., Chan, L. N., Tripathi, V., Lu, J., Kwon, O., Popescu, N. C., Lowy, D. R., & Tamanoi, F. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-198 · Cited by 39
Monitoring the Cellular Effects of HMG-CoA Reductase Inhibitors In Vitro and Ex Vivo
Cicha, I., Schneiderhan-Marra, N., Yilmaz, A., Garlichs, C. D., & Goppelt-Struebe, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145943.19099.a3 · Cited by 37 · cited 17×
“Until recently, overexpression of both Rac1 and its splice variant Rac1b, together with deregulation of Rac1 regulators was considered the major mode of Rac1 signaling perturbation in cancer.6 However, advancements in screening methodologies have also enabled the identification of a number of activating mutations in R…”
BackgroundInfluentialFerri, N., Contini, A., Bernini, S. K., & Corsini, A. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a18bcc · Cited by 36 · cited 4×
“In addition to cancer, deregulation of Rac1 signaling has been shown to drive cardiovascular diseases.(7) For example, expression of constitutively active Rac1 in cardio-”
BackgroundInfluentialLim, J. S., Shin, M., Kim, H.-J., Kim, K. S., Choy, H. E., & Cho, K. A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu152 · Cited by 36
Stankiewicz, T. R., Loucks, F. A., Schroeder, E. K., Nevalainen, M. T., Tyler, K. L., Aktories, K., Bouchard, R. J., & Linseman, D. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302166 · Cited by 35
Abreu, J. R. F., Dontje, W., Krausz, S., de Launay, D., van Hennik, P. B., van Stalborch, A.-M. D., ten Klooster, J. P., Sanders, M. E., Reedquist, K. A., Vervoordeldonk, M. J., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2900 · Cited by 33
Dierkes, R., Warnking, K., Liedmann, S., Seyer, R., Ludwig, S., & Ehrhardt, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088520 · Cited by 33 · cited 1×
“indicated that NSC23766-mediated inhibition of Rac1 might have anti-viral properties.(154) Despite the promising results associated with”
BackgroundRac1 changes the substrate specificity of γ-secretase between amyloid precursor protein and Notch1
Boo, J. H., Sohn, J. H., Kim, J. E., Song, H., & Mook-Jung, I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.153 · Cited by 32 · cited 1×
“Additionally, inhibition of Rac1 was shown to reduce g-secretase-dependent APP cleavage.(133) Thus, via enhancing APP production and cleavage, Rac1, likely, plays an important role in the formation of the amyloid-b plaques observed in Alzheimer’s”
BackgroundZhu, S., Dai, J., Liu, H., Cong, X., Chen, Y., Wu, Y. R., Hu, H., Heng, B. C., Ouyang, H., & Zhou, Y. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39174 · Cited by 32 · cited 1×
“was associated with reduced chondrocyte hypertrophy in vitro and protected against cartilage degeneration in vivo.(138) This clearly highlights the therapeutic potential of targeting Rac1 to protect against osteoarthritis.”
BackgroundRajagopal, S., Ji, Y., Xu, K., Li, Y., Wicks, K., Liu, J., Wong, K., Herman, I. M., Isberg, R. R., & Buchsbaum, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.051490 · Cited by 29
Bettink, S., Werner, C. M., Chen, C., Müller, P., Schirmer, S. H., Walenta, K. L. H., Böhm, M., Laufs, U., & Friedrich, E. B. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.086 · Cited by 28 · cited 1×
“tion, the role of Rac1 in inflammation also implicates it in the formation of aortic aneurysms(113,114) and the initiation and progression of chronic heart failure.(115) Altogether, both in vitro and in vivo studies demon-”
BackgroundTalukder, M. A. H., Elnakish, M. T., Yang, F., Nishijima, Y., Alhaj, M. A., Velayutham, M., Hassanain, H. H., & Zweier, J. L. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00367.2012 · Cited by 26 · cited 1×
“neous development of cardiac hypertrophy, with mice being more susceptible to ischemic injury with notable increases in myocardial infarcted areas.(92,93) In addition to increased Rac1 activation, pathological cardiomyocyte hypertrophy is also associated with enhanced ROS production.”
BackgroundProteomic analysis of Rac1 signaling regulation by guanine nucleotide exchange factors
Marei, H., Carpy, A., Maček, B., & Malliri, A. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1183852 · Cited by 25 · cited 1×
“for the contrasting roles of these 2 GEFs in regulating Rac1-driven cell migration.(45,46) Thus, all together this”
BackgroundSelf-citation3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides: a new class of selective Rac inhibitors
Ferri, N., Bernini, S. K., Corsini, A., Clerici, F., Erba, E., Stragliotto, S., & Contini, A. (2012) · MedChemComm · doi:10.1039/c2md20328f · Cited by 25 · cited 1×
“to inhibit GEF-mediated Rac1 GTP loading via interfering with Rac1 binding to Tiam1, Trio and Vav2, thereby suppressing cell adhesion and Rac1-mediated cellular events.(156) Additionally, preliminary in vitro analysis demonstrated that this compound suppresses platelet-”
BackgroundNuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cells
Catalán, M. A. M., Cristóbal‐Mondragón, G. R., Adame-Gómez, J., del Valle-Flores, H. N., Coppe, J. F., Sierra-López, L., Romero-Hernández, M. A., Alarcón‐Romero, L. D. C., Illades‐Aguiar, B., & Castañeda-Saucedo, E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-116 · Cited by 25 · cited 1×
“as HaCat, suggesting a role of nuclear Rac1 in disease progression.(172) It was also shown that Rac1 nuclear accumulation mediates tumor cell invasion due to increased RhoA signaling in the cytoplasm.”
BackgroundPerturbation of cytoskeleton dynamics by the opposing effects of Rac1 and Rac1b
Nimnual, A. S., Taylor, L. J., Nyako, M., Jeng, H., & Bar‐Sagi, D. (2010) · Small GTPases · doi:10.4161/sgtp.1.2.14427 · Cited by 17
The conflicting role of Rac1 in inflammation
(2015) · Inflammation and Cell Signaling · doi:10.14800/ics.922 · Cited by 5
Cited by
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 876
Scheiblich, H., Eikens, F., Wischhof, L., Opitz, S., Jüngling, K., Cserép, C., Schmidt, S. V., Lambertz, J., Bellande, T., Pósfai, B., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.029 · Cited by 207
Fu, H., Alabdullah, M., Großmann, J., Spieler, F., Abdosh, R., Lutz, V., Kalies, K., Knöpp, K., Rieckmann, M., Koch, S., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2109-9 · Cited by 51
Tomino, T., Tajiri, H., Tatsuguchi, T., Shirai, T., Oisaki, K., Matsunaga, S., Sanematsu, F., Sakata, D., Yoshizumi, T., Maehara, Y., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.073 · Cited by 24
Chan, W. W. R., Li, W., Chang, R. C. C., & Lau, K. (2020) · The FASEB Journal · doi:10.1096/fj.202001703r · Cited by 20
Metadata
- Authors
- Marei, H., & Malliri, A.
- Venue
- Small GTPases
- Publisher
- Informa UK Limited
- Published
- 2016-07-21
- Volume
- 8
- Issue
- 3
- Pages
- 139-163
- ISSN
- 2154-1248 (ISSN-L)
- 2154-1256
- OpenAlex
- W2493059034
- Cited by
- 168
- References
- 178
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.